{"id":{"repo_id":"strathclyde","oai_identifier":"oai:strathclyde:pr76f345z"},"canonical_url":"https://search.ndltd.org/etd/strathclyde/oai:strathclyde:pr76f345z","repository":{"repo_id":"strathclyde","name":"University of Strathclyde","base_url":"https://stax.strath.ac.uk/catalog/oai"},"display":{"title":"A MAP2K7 genetic mouse model as an investigative tool of the cognitive and behavioural deficits in schizophrenia","abstract":"Schizophrenia is a devastating psychiatric disease affected by multiple factors, such as genetic, environmental and social. This study suggests a strong genetic contribution of the MAP2K7 candidate gene in risk for schizophrenia. It was reported earlier that the expression of MKK7/MAP2K7 kinase activated by glutamatergic activity is decreased in the post-mortem PFC from patients with schizophrenia, suggesting that reduced function of the MAP2K7-c-Jun N-terminal kinase (JNK) signalling cascade may offer an insight of neurochemical changes in schizophrenia. Current study investigates MAP2K7 heterozygous mice and suggests a schizophrenia-like cognitive phenotype of impaired working memory with a use of 8 radial arm maze and the n-back short-term memory performance task. Study also shows that potent NMDA-receptor antagonist ketamine treatment induces some alterations in the cerebral glucose uptake in the various brain regions and produces hypometabolism, however this pattern could be observed in both wild-type and MAP2K7 heterozygous mice. Therefore, the study introduces new evidence of altered expression of MAP2K7 gene and its effect on short-term working memory in mice, as well as ketamine-induced alterations of cerebral glucose uptake in numerous regions of the mice brain.","abstract_html":"Schizophrenia is a devastating psychiatric disease affected by multiple factors, such as genetic, environmental and social. This study suggests a strong genetic contribution of the MAP2K7 candidate gene in risk for schizophrenia. It was reported earlier that the expression of MKK7/MAP2K7 kinase activated by glutamatergic activity is decreased in the post-mortem PFC from patients with schizophrenia, suggesting that reduced function of the MAP2K7-c-Jun N-terminal kinase (JNK) signalling cascade may offer an insight of neurochemical changes in schizophrenia. Current study investigates MAP2K7 heterozygous mice and suggests a schizophrenia-like cognitive phenotype of impaired working memory with a use of 8 radial arm maze and the n-back short-term memory performance task. Study also shows that potent NMDA-receptor antagonist ketamine treatment induces some alterations in the cerebral glucose uptake in the various brain regions and produces hypometabolism, however this pattern could be observed in both wild-type and MAP2K7 heterozygous mice. Therefore, the study introduces new evidence of altered expression of MAP2K7 gene and its effect on short-term working memory in mice, as well as ketamine-induced alterations of cerebral glucose uptake in numerous regions of the mice brain.","abstract_has_math":false,"creators":["Ivanova, Natalja"],"institution":"University of Strathclyde","degree_name":"mres","degree_level":"masters-pg","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2013,"date_issued":"2013","date_published":"2013","updated_at":"2026-11-19T14:58:28Z","subjects":[],"languages":[],"rights":[],"rights_urls":["https://stax.strath.ac.uk/thesis_copyright_statement/"],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["10.48730/c53a-bp22"],"render_values":[{"text":"10.48730/c53a-bp22","href":"https://doi.org/10.48730/c53a-bp22","code":true}]},{"key":"dc:identifier","label":"Identifier","values":["T13640"],"render_values":[{"text":"T13640","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://stax.strath.ac.uk/concern/theses/pr76f345z","outbound_label":"Repository record","outbound_source":"dc:identifier.uri","record_url":"https://stax.strath.ac.uk/concern/theses/pr76f345z","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://stax.strath.ac.uk/catalog/oai?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Astrathclyde%3Apr76f345z","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Ivanova, Natalja"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2013"]},{"key":"dc:date.issued","label":"Date","values":["2013"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Strathclyde Institute of Pharmacy and Biomedical Sciences"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Strathclyde"]},{"key":"dc:relation.uri","label":"Dc Relation URI","values":["https://stax.strath.ac.uk/downloads/fb4948692","https://stax.strath.ac.uk/downloads/sx61dm59w"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["masters-pg"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["mres"]},{"key":"dc:type.uri","label":"Dc Type URI","values":["http://purl.org/coar/resource_type/c_bdcc"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights.uri","label":"Rights URI","values":["https://stax.strath.ac.uk/thesis_copyright_statement/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["T13640"]},{"key":"dc:identifier.doi","label":"DOI","values":["10.48730/c53a-bp22"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://stax.strath.ac.uk/concern/theses/pr76f345z"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Schizophrenia is a devastating psychiatric disease affected by multiple factors, such as genetic, environmental and social. This study suggests a strong genetic contribution of the MAP2K7 candidate gene in risk for schizophrenia. It was reported earlier that the expression of MKK7/MAP2K7 kinase activated by glutamatergic activity is decreased in the post-mortem PFC from patients with schizophrenia, suggesting that reduced function of the MAP2K7-c-Jun N-terminal kinase (JNK) signalling cascade may offer an insight of neurochemical changes in schizophrenia. Current study investigates MAP2K7 heterozygous mice and suggests a schizophrenia-like cognitive phenotype of impaired working memory with a use of 8 radial arm maze and the n-back short-term memory performance task. Study also shows that potent NMDA-receptor antagonist ketamine treatment induces some alterations in the cerebral glucose uptake in the various brain regions and produces hypometabolism, however this pattern could be observed in both wild-type and MAP2K7 heterozygous mice. Therefore, the study introduces new evidence of altered expression of MAP2K7 gene and its effect on short-term working memory in mice, as well as ketamine-induced alterations of cerebral glucose uptake in numerous regions of the mice brain."]},{"key":"dc:description.abstract","label":"Abstract","values":["Schizophrenia is a devastating psychiatric disease affected by multiple factors, such as genetic, environmental and social. This study suggests a strong genetic contribution of the MAP2K7 candidate gene in risk for schizophrenia. It was reported earlier that the expression of MKK7/MAP2K7 kinase activated by glutamatergic activity is decreased in the post-mortem PFC from patients with schizophrenia, suggesting that reduced function of the MAP2K7-c-Jun N-terminal kinase (JNK) signalling cascade may offer an insight of neurochemical changes in schizophrenia. Current study investigates MAP2K7 heterozygous mice and suggests a schizophrenia-like cognitive phenotype of impaired working memory with a use of 8 radial arm maze and the n-back short-term memory performance task. Study also shows that potent NMDA-receptor antagonist ketamine treatment induces some alterations in the cerebral glucose uptake in the various brain regions and produces hypometabolism, however this pattern could be observed in both wild-type and MAP2K7 heterozygous mice. Therefore, the study introduces new evidence of altered expression of MAP2K7 gene and its effect on short-term working memory in mice, as well as ketamine-induced alterations of cerebral glucose uptake in numerous regions of the mice brain."]},{"key":"dc:title","label":"Title","values":["A MAP2K7 genetic mouse model as an investigative tool of the cognitive and behavioural deficits in schizophrenia"]}]}],"canonical_facts":{"dc:creator":["Ivanova, Natalja"],"dc:date":["2013"],"dc:date.issued":["2013"],"dc:description":["Schizophrenia is a devastating psychiatric disease affected by multiple factors, such as genetic, environmental and social. This study suggests a strong genetic contribution of the MAP2K7 candidate gene in risk for schizophrenia. It was reported earlier that the expression of MKK7/MAP2K7 kinase activated by glutamatergic activity is decreased in the post-mortem PFC from patients with schizophrenia, suggesting that reduced function of the MAP2K7-c-Jun N-terminal kinase (JNK) signalling cascade may offer an insight of neurochemical changes in schizophrenia. Current study investigates MAP2K7 heterozygous mice and suggests a schizophrenia-like cognitive phenotype of impaired working memory with a use of 8 radial arm maze and the n-back short-term memory performance task. Study also shows that potent NMDA-receptor antagonist ketamine treatment induces some alterations in the cerebral glucose uptake in the various brain regions and produces hypometabolism, however this pattern could be observed in both wild-type and MAP2K7 heterozygous mice. Therefore, the study introduces new evidence of altered expression of MAP2K7 gene and its effect on short-term working memory in mice, as well as ketamine-induced alterations of cerebral glucose uptake in numerous regions of the mice brain."],"dc:description.abstract":["Schizophrenia is a devastating psychiatric disease affected by multiple factors, such as genetic, environmental and social. This study suggests a strong genetic contribution of the MAP2K7 candidate gene in risk for schizophrenia. It was reported earlier that the expression of MKK7/MAP2K7 kinase activated by glutamatergic activity is decreased in the post-mortem PFC from patients with schizophrenia, suggesting that reduced function of the MAP2K7-c-Jun N-terminal kinase (JNK) signalling cascade may offer an insight of neurochemical changes in schizophrenia. Current study investigates MAP2K7 heterozygous mice and suggests a schizophrenia-like cognitive phenotype of impaired working memory with a use of 8 radial arm maze and the n-back short-term memory performance task. Study also shows that potent NMDA-receptor antagonist ketamine treatment induces some alterations in the cerebral glucose uptake in the various brain regions and produces hypometabolism, however this pattern could be observed in both wild-type and MAP2K7 heterozygous mice. Therefore, the study introduces new evidence of altered expression of MAP2K7 gene and its effect on short-term working memory in mice, as well as ketamine-induced alterations of cerebral glucose uptake in numerous regions of the mice brain."],"dc:identifier":["T13640"],"dc:identifier.doi":["10.48730/c53a-bp22"],"dc:identifier.uri":["https://stax.strath.ac.uk/concern/theses/pr76f345z"],"dc:publisher.department":["Strathclyde Institute of Pharmacy and Biomedical Sciences"],"dc:publisher.institution":["University of Strathclyde"],"dc:relation.uri":["https://stax.strath.ac.uk/downloads/fb4948692","https://stax.strath.ac.uk/downloads/sx61dm59w"],"dc:rights.uri":["https://stax.strath.ac.uk/thesis_copyright_statement/"],"dc:title":["A MAP2K7 genetic mouse model as an investigative tool of the cognitive and behavioural deficits in schizophrenia"],"dc:type.qualificationlevel":["masters-pg"],"dc:type.qualificationname":["mres"],"dc:type.uri":["http://purl.org/coar/resource_type/c_bdcc"]},"updated_at":"2026-11-19T14:58:28Z"}